“…Globally, approximately 216 million people live with moderate to severe visual impairment ( Bourne, Flaxman, Braithwaite, Cicinelli, Das, Jonas, et al, 2017 ), with these numbers predicted to rise over coming decades due to an aging population ( Access Economics Pty Ltd, 2009 ; Pezzullo, Streatfeild, Simkiss, & Shickle, 2018 ). Although for many people sight loss cannot be reversed or cured, low vision aids (LVAs) can have a positive impact on residual functional sight ( Crossland, Starke, Imielski, Wolffsohn, & Webster, 2019 ; Binns, Bunce, Dickinson, Harper, Tudor-Edwards, Woodhouse, et al, 2012 ; Hooper, Jutai, Strong, & Russell-Minda, 2008 ; Peterson, Wolffsohn, Rubinstein, & Lowe, 2003 ; Virgili, Acosta, Bentley, Giacomelli, Allcock, & Evans, 2018 ), with a prominent research focus on restoring the ability to read ( Virgili et al, 2018 ). Optical low vision aids tend to be task specific, with constraints on magnification, field of view, working distance, and ease of use: stronger optical magnifiers typically have a smaller field of view, are harder to align, and are more affected by hand movement than weaker devices.…”